Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA2324 SG3199Summary: SG3199 is a cytotoxic DNA minor groove interstrand cross-linked PBD dimer. -
BA2325 PNU-159682Summary: PNU-159682, a metabolite of anthracycline neomycin, is a DNA topoisomerase II inhibitor with excellent cytotoxicity. -
BA2326 TaltobulinSummary: Taltobulin (HTI-286) is a synthetic tripeptide cysteine analog, Taltobulin is a potent anti-microtubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. -
BA2327 Seco-DUBASummary: Seco-DUBA is a doxorubicin (DUBA) prodrug containing two hydroxyl groups, each of which can be coupled to an antibody via a linker. -
BA2328 SJG-136Summary: SJG-136 is an effective DNA cross-linking agent. -
BA2331 MaytansinolSummary: Maytansinol (AnsamitocinP-0) is a derivative of Medenin. -
BA2332 SG2057Summary: SG2057 (DRG16) is a PBD dimer containing a glutaraldehyde bond that selectively binds sequences in the minor groove to form inter- and intra-strand cross-linked adducts of DNA. -
BA2344 DRF-1042Summary: DRF-1042 is an orally active camptothecin analog with inhibitory effects on DNA topoisomerase I. -
BA2349 Gly-7-MAD-MDCPTSummary: Gly-7-MAD-MDCPT is an anticancer agent. -
BA2351 TH1338Summary: TH1338, an orally active derivative of camptothecin, is a promising anticancer compound that exhibits excellent tumor cytotoxicity in vitro.

